Christopher Cabanski

Senior Director, Network Clinical Research at Parker Institute for Cancer Immunotherapy

Chris Cabanski, PhD, is Senior Director, Network Clinical Research at PICI. He is responsible for engaging with the PICI Network and PICI collaboration partners on emerging clinical research and facilitating the clinical trial design and operation of such investigator-sponsored research in multi-center settings.

Cabanski’s career interests include clinical trial design, data visualization and biomarker analysis. He previously led the biostatistics, data management and clinical science groups that were responsible for the collection, analysis and interpretation of clinical data for all PICI-sponsored trials. Prior to PICI, he worked as a senior biostatistician at Genentech, where he helped develop several early-stage molecules across various immunological diseases including asthma, idiopathic pulmonary fibrosis and chronic spontaneous urticaria. He completed postdoctoral training in the laboratory of Christopher Maher at The Genome Institute at Washington University School of Medicine in St. Louis, where he analyzed thousands of cancer transcriptomes to identify long noncoding RNAs (lncRNAs) that are commonly dysregulated across multiple cancer types.

Links